Clinical Trial

Safest Choice of Antihypertensive Regimen for Postpartum Hypertension

Study acronym: SCARPH
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this investigator-initiated randomized control trial is to determine whether oral Nifedipine versus oral Labetalol is superior in controlling high blood pressures in the postpartum period.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-09-19; most recent amendment 2026-02-02.
Status change: Not Yet Recruiting → Recruiting 2023-03-22
Trial Details
NCT Number NCT05551104
Lead Sponsor Loma Linda University
Conditions Postpartum Complication, Maternal Hypertension, High Blood Pressure
Enrollment 500 participants
Start Date 2023-05-08
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-04